(Q46457059)

22 December 2017

title

Low-frequency ultrasound as a transcutaneous immunization adjuvant (English)

1 reference

22 December 2017

0 references

4

Samir Mitragotri

1 reference

22 December 2017

Zancong Shen

series ordinal

3

object named as

Zancong Shen

1 reference

22 December 2017

Sumit Paliwal

series ordinal

2

object named as

Sumit Paliwal

1 reference

22 December 2017

author name string

Ahmet Tezel

series ordinal

1

1 reference

22 December 2017

language of work or name

English

0 references

publication date

16 March 2005

1 reference

22 December 2017

published in

Vaccine

1 reference

22 December 2017

volume

23

1 reference

22 December 2017

issue

29

1 reference

22 December 2017

page(s)

3800-3807

1 reference

22 December 2017

Feasibility of aerosol vaccination in humans

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Needle-free epidermal powder immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Immune response to a mucosally administered aflatoxin B1 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Skin immunization made possible by cholera toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Migration of dendritic cells into lymphatics-the Langerhans cell example: routes, regulation, and relevance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Immunization onto shaved skin with a bacterial enterotoxin adjuvant protects mice against respiratory syncytial virus (RSV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Frequency dependence of sonophoresis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Description of transdermal transport of hydrophilic solutes during low-frequency sonophoresis based on a modified porous pathway model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Determination of threshold energy dose for ultrasound-induced transdermal drug transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Integrity of the permeability barrier regulates epidermal Langerhans cell density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Langerhans cells in acute and chronic epidermal lesions of atopic dermatitis, observed by L-dopa histofluorescence, glycol methacrylate thin secretion, and electron microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Langerhans cell accumulation in chronic tinea pedis and pityriasis versicolor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Iontophoresis and sonophoresis stimulate epidermal cytokine expression at energies that do not provoke a barrier abnormality: lamellar body secretion and cytokine expression are linked to altered epidermal calcium levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Induction by tumour necrosis factor alpha of dose-related changes in Langerhans cell frequency in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Rapid onset of cutaneous anesthesia with EMLA cream after pretreatment with a new ultrasound-emitting device.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Transdermal monitoring of glucose and other analytes using ultrasound.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.027

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.02.027

1 reference

22 December 2017

PubMed ID

15893617

1 reference

22 December 2017